Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-François Rosier is active.

Publication


Featured researches published by Jean-François Rosier.


Radiotherapy and Oncology | 1998

Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation

Jean-François Rosier; Vincent Grégoire; Hubert Counoy; Michelle Octave-Prignot; Philippe Rombaut; Pierre Scalliet; Fabienne Vanderlinden; Marc Hamoir

PURPOSE The aim of this study was to retrospectively compare the efficacy and functional results of three treatment options for T1N0M0 glottic carcinomas applied in a single institution. MATERIALS AND METHODS One hundred six charts of patients with biopsy-proven T1N0M0 glottic carcinomas treated between 1979 and 1995 were reviewed. There were 81 T1a and 25 T1b tumors. Forty-one patients were treated by radiotherapy (RT) (median dose of 64 Gy), 34 patients were treated by partial laryngectomy (PL) and 31 patients were treated by laser microsurgery (L) of which 10 received postoperative RT for positive margins. In 18 patients, a perceptual voice rating on a visual scale was performed by the patients themselves, three non-speech specialists and two speech therapists. RESULTS With a median follow-up time of 63.5 months, the 5- and 10-year loco-regional control probabilities reached 91 and 87%, respectively, without any difference between the treatment groups. After salvage laryngectomy, the 5- and 10-year loco-regional control probabilities reached 97% without any difference between the treatment groups. For the whole population, overall survival reached 78 and 62.4% at 5 and 10 years, respectively. The actuarial incidence of second primary reached 19% at 10 years. Regarding the quality of voice, overall there was a trend towards a worse satisfaction index, more hoarseness and more breathiness after PL than after L or RT. CONCLUSIONS Our data suggested that assuming proper selection of patients, RT and L yielded similar outcomes and functional results. Local recurrence can be adequately salvaged by surgery. On the other hand, PL appeared to yield similar loco-regional control probability but with a worse quality of voice.


Radiotherapy and Oncology | 1999

Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy

Vincent Grégoire; Marc Hamoir; Jean-François Rosier; Hubert Counoy; Louis Eeckhoudt; Niels Neymark; Pierre Scalliet


Radiotherapy and Oncology | 2001

Proton RBE for early intestinal tolerance in mice after fractionated irradiation

John Gueulette; Jacobus P. Slabbert; Lothar Böhm; Blanche M. De Coster; Jean-François Rosier; Michelle Octave-Prignot; Arnout C.C. Ruifrok; A Nicolaas Schreuder; André Wambersie; Pierre Scalliet; D. T. L. Jones


Radiotherapy and Oncology | 2002

Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro

Vincent Grégoire; Jean-François Rosier; Marc De Bast; M Bruniaux; Blanche M. De Coster; Michelle Octave-Prignot; Pierre Scalliet


Mutation Research | 2003

The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.

Jean-François Rosier; Lucienne Michaux; Geneviève Ameye; Björn Cedervall; Jeanne-Marie Libouton; M. Octaveprignot; Christine Verellen-Dumoulin; Pierre Scalliet; Vincent Grégoire


Radiotherapy and Oncology | 2004

Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.

Jean-François Rosier; M Bruniaux; Bernard Husson; Michelle Octave-Prignot; M. Beauduin; Vincent Grégoire


European Journal of Cancer | 1997

The role of gemcitabine-induced cell cycle synchronization in radiosensitization of A SCC61 human head & neck squamous carcinoma cell (HNSCC) line

Jean-François Rosier; M. Beauduin; M Bruniaux; B M De Coster; M. De Bast; Pierre Scalliet; Vincent Grégoire


European Journal of Cancer | 1997

Cost-effectiveness in T1N0 glottic squamous cell carcinomas (SCC): Comparison between radiotherapy (RT), laser microsurgery (L) and partial laryngectomy (PL)

Vincent Grégoire; Marc Hamoir; J. Bussels; L. Eeckoudt; Hubert Counoy; Jean-François Rosier; Pierre Scalliet


Radiotherapy and Oncology | 1996

46 Therapeutic strategies in t& No Mo glottic carcinomas. A retrospective evaluation

Jean-François Rosier; Hubert Counoy; Marc Hamoir; P. Lachmbre; Pierre Scalliet; Vincent Grégoire


Radiotherapy and Oncology | 1996

329Effect of 2′,2′-difluorodeoxycytidine (Gemcitabine) on in vivo radiotolerance of mouse jejunum, and its association with the pharmacodynamics of DNA synthesis inhibition

Vincent Grégoire; B M De Coster; Jean-François Rosier; M. Beauduin; M Bruniaux; M. Octaveprignot; Pierre Scalliet

Collaboration


Dive into the Jean-François Rosier's collaboration.

Top Co-Authors

Avatar

Pierre Scalliet

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar

Vincent Grégoire

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Hubert Counoy

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

M Bruniaux

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

M. Beauduin

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Marc Hamoir

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Michelle Octave-Prignot

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

B M De Coster

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Blanche M. De Coster

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

M. Octaveprignot

Catholic University of Leuven

View shared research outputs
Researchain Logo
Decentralizing Knowledge